Current results of the screening program at the division of cancer treatment, national cancer institute
- 1 February 1981
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer (1965)
- Vol. 17 (2), 129-142
- https://doi.org/10.1016/0014-2964(81)90027-x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomasCancer, 1977
- Neocarzinostatin (NSC 157365) a New Cancerostatic CompoundOncology, 1976
- Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancerCancer, 1975
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesEuropean Journal of Cancer (1965), 1974
- Aspartate TranscarbamylaseJournal of Biological Chemistry, 1971
- Further investigation of the relation between the clinical and tissue culture response to chemotherapeutic agents on human cancerCancer, 1962
- A Clinical Study of the Comparative Effect of Nitrogen Mustard and DON in Patients With Bronchogenic Carcinoma, Hodgkin's Disease, Lymphosarcoma, and Melanoma2JNCI Journal of the National Cancer Institute, 1959
- Investigation of the Relation between Clinical and Tissue-Culture Response to Chemotherapeutic Agents on Human CancerNew England Journal of Medicine, 1957
- Pharmacological and initial therapeutic observations on 6-Diazo-5-Oxo-L-Norleucine (Don) in human neoplastic diseaseCancer, 1957